EUVIMEDEUVIMED entdecken
Crossref

Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376

Cheng Lin, Zhimin Zhu, Haihai Jiang, Xiaofang Zou, Xiangyi Zeng, Jie Wang, Pei Zeng, Wenwen Li, Xuelan Zhou, Jin Zhang, Qisheng Wang, Jian Li

Journal of Molecular Biology · 2024-03 · 436 (6) · 168474

DOI: 10.1016/j.jmb.2024.168474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Biology, 2024-03. Verfasst von Cheng Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Gannan Medical University, Ganzhou 341000, China. Hauptthemen laut MEDLINE: Antiviral Agents, Coronavirus, Lactams, Leucine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Science Fund for Distinguished Young Scholars of Guangxi Province, Gannan Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main protease (Mpro) of coronaviruses participates in viral replication, serving as a hot target for drug design. GC376 is able to effectively inhibit the activity of Mpro, which is due to nucleophilic addition of GC376 by binding covalently with Cys145 in Mpro active site. Here, we used fluorescence resonance energy transfer (FRET) assay to analyze the IC50 values of GC376 against Mpros from six different coronaviruses (SARS-CoV-2, HCoV-229E, HCoV-HUK1, MERS-CoV, SARS-CoV, HCoV-NL63) and five Mpro mutants (G15S, M49I, K90R, P132H, S46F) from SARS-CoV-2 variants. The results showed that GC376 displays effective inhibition to various coronaviral Mpros and SARS-CoV-2 Mpro mutants. In addition, the crystal structures of SARS-CoV-2 Mpro (wide type)-GC376, SARS-CoV Mpro-GC376, MERS-CoV Mpro-GC376, and SARS-CoV-2 Mpro mutants (G15S, M49I, S46F, K90R, and P132H)-GC376 complexes were solved. We found that GC376 is able to fit into the active site of Mpros from different coronaviruses and different SARS-CoV-2 variants properly. Detailed structural analysis revealed key molecular determinants necessary for inhibition and illustrated the binding patterns of GC376 to these different Mpros. In conclusion, we not only proved the inhibitory activity of GC376 against different Mpros including SARS-CoV-2 Mpro mutants, but also revealed the molecular mechanism of inhibition by GC376, which will provide scientific guidance for the development of broad-spectrum drugs against SARS-CoV-2 as well as other coronaviruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCoronavirusLactamsLeucineSulfonic AcidsCoronavirus 3C ProteasesHumansSARS-CoV-2

Stichwörter der Autor:innen

crystalmutationproteinsuppressantvirus

Substanzen

Antiviral AgentsGC376LactamsLeucineSulfonic AcidsCoronavirus 3C Proteases

Autor:innen und Institutionen

  • College of Pharmacy, Gannan Medical University, Ganzhou 341000, China.
  • Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China.
  • School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.
  • Shenzhen Crystalo Biopharmaceutical Co, Ltd, Shenzhen 518118, China; Jiangxi Jmerry Biopharmaceutical Co, Ltd, Ganzhou 341000, China.
  • School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. Electronic address: zhangxiaokong@hotmail.com.
  • Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China; Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201204, China. Electronic address: wangqs@sari.ac.c…

Förderung

  • Science Fund for Distinguished Young Scholars of Guangxi Province
  • Gannan Medical University
  • National Natural Science Foundation of China
  • Guangxi Key Research and Development Program
  • Natural Science Foundation of Jiangxi Province
  • Jiangxi University Collaborative Innovation Center for the Modern Technology and Industrial Development of Jiangxi Minority Traditional Medicine

Zitieren

APA

Lin, C., Zhu, Z., Jiang, H., Zou, X., Zeng, X., Wang, J., Zeng, P., Li, W., Zhou, X., Zhang, J., Wang, Q., & Li, J. (2024). Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376. Journal of Molecular Biology, 436(6), 168474. https://doi.org/10.1016/j.jmb.2024.168474

Vancouver

Lin C, Zhu Z, Jiang H, Zou X, Zeng X, Wang J, et al. Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376. Journal of Molecular Biology. 2024;436(6):168474. doi:10.1016/j.jmb.2024.168474

BibTeX
@article{Lin2024,
  author = {Lin, Cheng and Zhu, Zhimin and Jiang, Haihai and Zou, Xiaofang and Zeng, Xiangyi and Wang, Jie and Zeng, Pei and Li, Wenwen and Zhou, Xuelan and Zhang, Jin and Wang, Qisheng and Li, Jian},
  title = {Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376},
  journal = {Journal of Molecular Biology},
  year = {2024},
  volume = {436},
  number = {6},
  pages = {168474},
  doi = {10.1016/j.jmb.2024.168474}
}
Kostenlos starten →